主管单位:中华人民共和国
国家卫生健康委员会
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:30.00元
全年:360.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Wang Juanying Li Longyang Wang Anna Chen Qianqian Zhao Yaning Li Shuxing
英文单位:College of Nursing and Rehabilitation North China University of Science and Technology Tangshan 063210 China
英文关键词:Respiratorysarcopeniacomorbidwithlungcancer;Pathogenesis;Managementstrategies
老年人共病是目前全球关注的热点之一,老年肺癌共病呼吸性肌少症严重降低患者的治疗效果和耐受性,使其生活质量及功能状态恶化,甚至直接增加死亡风险,其对长期医疗和护理管理的需求给医疗系统造成了极大压力。目前关于两种疾病共病的发病机制尚不清楚。本文介绍老年肺癌共病呼吸性肌少症的流行病学现状,分析肺癌共病呼吸性肌少症的发生机制及两种疾病共同的危险因素,总结改善其呼吸肌力及增加肌肉量的干预措施,以期为医护人员对老年肺癌共病呼吸性肌少症的研究和管理提供参考依据,从而改善老年肺癌患者的预后,优化其生存质量。
Comorbidity in the elderly is one of the global research hotspots at present. Respiratory sarcopenia comorbid with lung cancer in the elderly seriously impairs the therapeutic efficacy and tolerance of patients, exacerbates their quality of life and functional status, and even directly increases the risk of death. The demand for long-term medical and nursing management brings enormous pressure to the medical system. At present, the pathogenesis of the comorbidity of these two diseases remains unclear. This article introduces the epidemiological status of respiratory sarcopenia comorbid with lung cancer in the elderly, analyzes the pathogenesis of lung cancer complicated with respiratory sarcopenia and the common risk factors of the two diseases, and summarizes the intervention measures to improve respiratory muscle strength and increase muscle mass. It is expected to provide a reference for medical staff in the research and management of respiratory sarcopenia comorbid with lung cancer in the elderly, thereby improving the prognosis and optimizing the quality of life of elderly patients with lung cancer.
copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。